BRPI0508928A - fator de permissividade celular para vìrus e usos do mesmo - Google Patents

fator de permissividade celular para vìrus e usos do mesmo

Info

Publication number
BRPI0508928A
BRPI0508928A BRPI0508928-0A BRPI0508928A BRPI0508928A BR PI0508928 A BRPI0508928 A BR PI0508928A BR PI0508928 A BRPI0508928 A BR PI0508928A BR PI0508928 A BRPI0508928 A BR PI0508928A
Authority
BR
Brazil
Prior art keywords
viruses
factor
permissiveness
cellular
cellular permissiveness
Prior art date
Application number
BRPI0508928-0A
Other languages
English (en)
Inventor
Jay Gregory Calvert
Shelly Lynn Shields
David Ewell Slade
Siao-Kun Wan Welch
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of BRPI0508928A publication Critical patent/BRPI0508928A/pt
Publication of BRPI0508928B1 publication Critical patent/BRPI0508928B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0688—Cells from the lungs or the respiratory tract
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/12011—Asfarviridae
    • C12N2710/12051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

FATOR DE PERMISSIVIDADE CELULAR PARA VìRUS E USOS DO MESMO. A presente invenção fornece processos e composições relacionados com a produção de células hospedeiras permissivas para o crescimento de vírus, particularmente o vírus das Síndromes Reprodutiva e Respiratória Suínas (PRRS).
BRPI0508928A 2004-04-23 2005-04-05 Processo de falicitação da infecção de uma célula de vertebrado por PRRSV e para medir a propensão de uma linhagem de células teste à referida infecção BRPI0508928B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US56521404P 2004-04-23 2004-04-23
US60/565,214 2004-04-23
US63473604P 2004-12-09 2004-12-09
US60/634,736 2004-12-09
PCT/US2005/011502 WO2005107796A2 (en) 2004-04-23 2005-04-05 Cellular permissivity factor for viruses, and uses thereof

Publications (2)

Publication Number Publication Date
BRPI0508928A true BRPI0508928A (pt) 2007-08-14
BRPI0508928B1 BRPI0508928B1 (pt) 2015-10-06

Family

ID=35320736

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0508928A BRPI0508928B1 (pt) 2004-04-23 2005-04-05 Processo de falicitação da infecção de uma célula de vertebrado por PRRSV e para medir a propensão de uma linhagem de células teste à referida infecção

Country Status (21)

Country Link
US (4) US7754464B2 (pt)
EP (2) EP1742658B1 (pt)
JP (2) JP5273642B2 (pt)
CN (1) CN102220289B (pt)
AR (3) AR049033A1 (pt)
AU (2) AU2005240002B2 (pt)
BR (1) BRPI0508928B1 (pt)
CA (1) CA2564769C (pt)
CL (1) CL2008002323A1 (pt)
DK (1) DK1742658T3 (pt)
EA (1) EA013071B1 (pt)
ES (2) ES2570665T3 (pt)
IL (1) IL178160A0 (pt)
MA (1) MA28544B1 (pt)
MX (1) MXPA06012216A (pt)
NO (1) NO341211B1 (pt)
NZ (1) NZ550145A (pt)
PL (1) PL1742658T3 (pt)
TW (2) TWI438278B (pt)
UY (1) UY28867A1 (pt)
WO (1) WO2005107796A2 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA013071B1 (ru) * 2004-04-23 2010-02-26 ФАРМАЦИЯ ЭНД АПДЖОН КОМПАНИ ЭлЭлСи Способ получения вируса репродуктивно-респираторного синдрома свиней (pprsv) и способ получения pprsv вакцины
MX2009007457A (es) * 2007-01-12 2009-08-12 Univ Illinois Celulas que no son de mono para el desarrollo del virus del sindrome porcino reproductor y respiratorio (prrs).
ES2567561T3 (es) * 2007-07-27 2016-04-25 Universiteit Gent Células permisivas y sus usos
UA108902C2 (uk) * 2010-11-10 2015-06-25 Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
KR102012109B1 (ko) * 2012-05-17 2019-08-19 조에티스 엘엘씨 이유 전 돼지 생식기 호흡기 증후군(prrs) 바이러스에 대한 효과적인 백신접종
CN103525766B (zh) * 2013-03-24 2015-06-17 西北农林科技大学 一种猪肾细胞系及其应用
GB201313235D0 (en) 2013-07-24 2013-09-04 Univ Edinburgh Antiviral Compositions Methods and Animals
CN104459160A (zh) * 2014-12-30 2015-03-25 洛阳普莱柯万泰生物技术有限公司 试剂盒及其制备方法和使用方法
GB201617559D0 (en) 2016-10-17 2016-11-30 University Court Of The University Of Edinburgh The Swine comprising modified cd163 and associated methods
CA3047294A1 (en) * 2016-12-14 2018-06-21 Zoetis Services Llc Effective vaccination against european strains of porcine reproductive and respiratory syndrome (prrs) virus prior to weaning
CN108103099B (zh) * 2017-12-18 2022-03-04 中山大学 一种抗蓝耳病Marc-145细胞系及其制备方法和应用
CN108893450B (zh) * 2018-08-13 2022-04-19 江苏省农业科学院 先天性免疫系统重构的bhk21细胞群及其细胞克隆增毒应用
CN111996213A (zh) * 2020-02-06 2020-11-27 广西大学 猪繁殖与呼吸综合征病毒双荧光标记基因重组毒株的构建方法
KR102254246B1 (ko) * 2020-03-23 2021-05-20 큐벳 주식회사 항-cd163 항체 또는 이의 항원 결합 단편을 인코딩하는 핵산 분자 및 이를 포함하는 아데노바이러스 벡터, 및 이의 아프리카 돼지열병의 예방 또는 치료용도
US11796548B2 (en) * 2020-04-22 2023-10-24 The United States Of America, As Represented By The Secretary Of Agriculture Continuous stable cell line for identification of infectious African swine fever virus in clinical samples
CN120302994A (zh) 2022-12-06 2025-07-11 硕腾服务有限责任公司 用于针对prrs-1病毒对仔猪进行疫苗接种的方法和组合物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4517288A (en) 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
CA1291031C (en) 1985-12-23 1991-10-22 Nikolaas C.J. De Jaeger Method for the detection of specific binding agents and their correspondingbindable substances
CA1303983C (en) 1987-03-27 1992-06-23 Robert W. Rosenstein Solid phase assay
WO1990005183A1 (en) 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
GB2236186B (en) 1989-08-22 1994-01-05 Finnigan Mat Gmbh Process and device for laser desorption of analyte molecular ions, especially of biomolecules
HU217212B (hu) 1989-12-22 1999-12-28 Applied Research Systems, ARS Holding M.V. Endogén gének expressziójának módosítása szabályozóelemmel
WO1991018982A1 (en) 1990-06-05 1991-12-12 Immunex Corporation Type ii interleukin-1 receptors
AU664847B2 (en) 1991-05-15 1995-12-07 Cell Genesys, Inc. Genomic modifications with homologous DNA targeting
US5846805A (en) 1991-08-26 1998-12-08 Boehringer Ingelheim Animal Health, Inc. Culture of swine infertility and respiratory syndrome virus in simian cells
US5514545A (en) 1992-06-11 1996-05-07 Trustees Of The University Of Pennsylvania Method for characterizing single cells based on RNA amplification for diagnostics and therapeutics
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
WO1994028418A1 (en) 1993-05-28 1994-12-08 Baylor College Of Medicine Method and apparatus for desorption and ionization of analytes
ES2165405T3 (es) * 1994-04-11 2002-03-16 Akzo Nobel Nv Cepas de vacuna europeas del virus del sindrome reproductor y respiratorio porcino (prrsv).
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
WO1998035023A1 (en) * 1997-02-07 1998-08-13 Origen, Inc. Method for growing porcine reproductive and respiratory syndrome virus for use as vaccines and diagnostic assays
US6740490B2 (en) 2001-01-29 2004-05-25 Kansas State University Research Foundation Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding
EP1414984B1 (en) 2001-07-24 2018-07-04 Universiteit Gent Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
WO2003100419A1 (en) * 2002-05-27 2003-12-04 Bioceros B.V. Methods for using the cd163 pathway for modulating an immune response
EA013071B1 (ru) * 2004-04-23 2010-02-26 ФАРМАЦИЯ ЭНД АПДЖОН КОМПАНИ ЭлЭлСи Способ получения вируса репродуктивно-респираторного синдрома свиней (pprsv) и способ получения pprsv вакцины

Also Published As

Publication number Publication date
EP1742658A2 (en) 2007-01-17
HK1109065A1 (en) 2008-05-30
JP5273642B2 (ja) 2013-08-28
CN102220289B (zh) 2014-05-21
EP1742658B1 (en) 2014-12-24
AR084529A2 (es) 2013-05-22
EA200601677A1 (ru) 2007-10-26
BRPI0508928B1 (pt) 2015-10-06
JP2007533321A (ja) 2007-11-22
EP1742658A4 (en) 2007-11-28
ES2530694T3 (es) 2015-03-04
MXPA06012216A (es) 2007-01-17
AR049033A1 (es) 2006-06-21
CA2564769A1 (en) 2005-11-17
US20120015425A1 (en) 2012-01-19
AU2009202410A1 (en) 2009-07-09
CL2008002323A1 (es) 2008-12-19
DK1742658T3 (en) 2015-01-19
PL1742658T3 (pl) 2015-05-29
TW200604343A (en) 2006-02-01
IL178160A0 (en) 2006-12-31
UY28867A1 (es) 2005-11-30
NO20065115L (no) 2006-11-06
US20140141492A1 (en) 2014-05-22
JP2013078324A (ja) 2013-05-02
US8486685B2 (en) 2013-07-16
US8058050B2 (en) 2011-11-15
JP5600340B2 (ja) 2014-10-01
AU2005240002B2 (en) 2009-06-18
US9102912B2 (en) 2015-08-11
TWI438278B (zh) 2014-05-21
NZ550145A (en) 2009-07-31
US20050271685A1 (en) 2005-12-08
US7754464B2 (en) 2010-07-13
TWI354025B (en) 2011-12-11
US20100273238A1 (en) 2010-10-28
EP2520310B1 (en) 2016-03-30
AU2005240002A1 (en) 2005-11-17
MA28544B1 (fr) 2007-04-03
CN102220289A (zh) 2011-10-19
EA013071B1 (ru) 2010-02-26
WO2005107796A3 (en) 2007-04-12
TW201134944A (en) 2011-10-16
EP2520310A1 (en) 2012-11-07
WO2005107796A2 (en) 2005-11-17
NO341211B1 (no) 2017-09-11
AR084530A2 (es) 2013-05-22
CA2564769C (en) 2013-12-17
ES2570665T3 (es) 2016-05-19

Similar Documents

Publication Publication Date Title
ATE460473T1 (de) Immortalisierte entezelllinien zur viruserzeugung
CL2008002076A1 (es) Compuestos derivados de ariloxazoles sustituidos; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar diabetes, sindrome metabolico, dislipidemias, entre otras enfermedades.
NO20171811A1 (no) Fremgangsmåte for fremstilling av (1R,2R)-3-(3-dimetylamino-1-etyl-2-metyl-propyl)-fenol
ECSP077271A (es) Derivados de pirimidina
DE602006017725D1 (de) Nukleinsäuren, kodierend für impfstoffe gegen den reproduktiven und respiratorischen syndrom virus (prrsv)
WO2009024239A3 (en) Permissive cells and uses thereof
WO2007048089A3 (en) Multi-plasmid system for the production of influenza virus
ECSP077259A (es) Derivados de pirimidina
WO2007031548A3 (en) Processes for preparing of glucopyranosyl-substituted (ethynyl-benzyl)-benzene derivatives and intermediates thereof
ATE491722T1 (de) Herstellung und reinigung von il-29
NO20082376L (no) Farmasoytiske sammensetninger
ATE550037T1 (de) Zusammensetzungen gegen das sars-coronavirus und ihre verwendungen
BRPI0613770A2 (pt) anticorpos anti-cd26 e métodos de uso destes
CR9339A (es) Formas farmaceuticas con propiedades farmacocineticas mejoradas
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
UY28867A1 (es) Factor de permisividad celular para virus y usos del mismo
DE602007008360D1 (de) Aviäre telomerase reverse transkriptase
MX2009007457A (es) Celulas que no son de mono para el desarrollo del virus del sindrome porcino reproductor y respiratorio (prrs).
ATE479440T1 (de) Virusstämme und zusammensetzungen des prrs- syndroms (porcine reproductive und respiratory syndrome) von schweinen
BR112014014255A2 (pt) processos de produção de magnolol e derivados do mesmo
UY30952A1 (es) Polimorfos de s,s-dioxido del acido 7-[3-cloro-6,11-dihidro-6-metildibenzo[c,f][1,2]tiazepin-11-ilamino]heptanoico y métodos para su preparacion y uso
TNSN07139A1 (en) 4-hydroxy tamoxifen gel formulations
UY26978A1 (es) Nuevas sulfoxibenzamidas
DOP2006000089A (es) Derivados de tetrahidronaftalina, procedimientos para su preparacion y uso como antiinflamatorios.
UA6286U (en) A method for the preparation of energy-intensive salts of some aminotetrazoles

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: PAH PANDU LLC (US)

B25D Requested change of name of applicant approved

Owner name: ZOETIS PANDU LLC (US)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/10/2015, OBSERVADAS AS CONDICOES LEGAIS.

B25G Requested change of headquarter approved
B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled
B25C Requirement related to requested transfer of rights
B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 39/12; C12Q 1/68; C12N 7/00; C12N 5/06; C12N 15/86.

Ipc: C12N 7/00 (2006.01), A61K 39/12 (2006.01), C07K 14

Ipc: C12N 7/00 (2006.01), A61K 39/12 (2006.01), C07K 14

B25A Requested transfer of rights approved
B25G Requested change of headquarter approved